Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin

Cancer Letters

Volumn 121, Issue 1, 1997, Pages 105-113

  Casas, Adriana ^a   Fukuda, Haydee ^a   Riley, Patrick ^b   Del C Batlle, Alcira M ^a  

^a Cd Univ Pabellon II 2do P   (Argentina)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

aminolevulinic acid; Adriamycin; Antitumour drugs; Combination therapy; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; DNA; DOXORUBICIN; FREE RADICAL; HYDROXYL RADICAL; MALONALDEHYDE; PEROXIDE; PORPHOBILINOGEN SYNTHASE; PORPHYRIN; REACTIVE OXYGEN METABOLITE; SEMIQUINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DRUG MECHANISM; DRUG TOXICITY; ENZYME ACTIVITY; HEART; INTRAPERITONEAL DRUG ADMINISTRATION; LASER; LIPID PEROXIDATION; LIVER; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ADENOCARCINOMA; AMINOLEVULINIC ACID; AMMONIA-LYASES; ANIMALS; DOXORUBICIN; DRUG THERAPY, COMBINATION; LIPID PEROXIDATION; LIVER; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MYOCARDIUM; NEOPLASM TRANSPLANTATION; PHOTOCHEMOTHERAPY; PORPHOBILINOGEN SYNTHASE; PORPHYRINS;

ANIMALIA;

EID: 0030833018     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00338-8     Document Type: Article

References (51)

1. Andreoni A., Colasanti A., Malatesta V., Roberti G. Phototoxicity of anthracyclines upon laser excitation in their long-wavelength absorption bands. Radiat. Res. 127:1991;24-29.
2. Baas P., Van Geel I., Oppelaar H., Meyer M., Beynen J., Van Zandwijk N., Stewart F. Enhancement of photodynamic therapy by mitomycin C: a preclinical and clinical study. Br. J. Cancer. 73:1996;945-951.
3. Batlle A., Ferramola A., Grinstein M. Purification and general properties of 5-aminolevulinate dehydratase from cow liver. Biochem. J. 194:1967;244-249.
4. Batlle A., Wider E., Stella A. A simple method for measuring erythrocyte porphobilinogenase and its use in the diagnosis of acute intermittent porphyria. Int. J. Biochem. 9:1978;871-875.
5. Berns M., Coffey J., Wile A. Laser photoradiation therapy of cancer: possible role of hyperthermia. Lasers Surg. Med. 4:1984;65-71.
6. Cantacuzino I., Ionescu-Mihaiesti C. Studies of the effects of associated photodynamic therapy and drugs on macromolecular synthesis of tumoral cells grown in vitro. Arch. Roum. Path. Exp. Microbiol. 49:1990;155-175.
7. Carmichael A., Riesz P. Photoinduced reactions of anthraquinone antitumor agents with peptides and nucleic acid bases: an electron spin resonance and spin trapping study. Arch. Biochem. Biophys. 237:1985;433-444.
8. A. Casas, H. Fukuda, A. Batlle, Potentiation of the 5-aminolevulinic acid-based photodynamic therapy with cyclophosphamide, Cancer Biochem. Biophys. 16 (1997) (in press).
9. Casas A., Fukuda H., Batlle A. Metabolic changes driven by cyclophosphamide treatment in mice. Cell Mol. Biol. 43:1997;95-101.
10. Cohen R., Nahabedian M., Terem T., Glenn D., Contino M., Berns M., Wile A. Potentiation of laser photoradiation therapy by chemotherapy. Curr. Surg. 42:1985;379-381.
11. Cowled P.A., Mackenzie L., Forbes I.J. Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. Cancer Res. 47:1987;971-974.
12. Creekmore S., Zaharko D. Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light. Cancer Res. 43:1983;5252-5257.
13. Daugherty J., Hixon S., Yielding K. Direct in vitro photoaffinity labelling of DNA with daunorubicin, adriamycin and rubidazone. Biochim. Biophys. Acta. 565:1979;13-21.
14. Diamond I., Granelli S., McDonagh A., Nielsen S., Wilson C., Jaenicke R. Photodynamic therapy of malignant tumors. Lancet. 2:1972;1175-1177.
15. DiMarco A. Adriamycin (NSC 123127): mode and mechanism of action. Cancer Chemother. Rep. 6:1975;91-106.
16. Dougherty T., Grindey G., Fiel R., Weishaupt K., Boyle D. Photoradiation therapy II: cure of animal tumors with hematoporphyrin and light. J. Natl. Cancer Inst. 55:1975;115-121.
17. T. Dougherty, W. Potter, D. Bellnier, Photodynamic therapy for the treatment of cancer: current status and advances, in: D. Kessel (Ed.), Photodynamic Therapy of Neoplastic Disease, CRC Press, Boca Raton, FL, 1990, pp. 1-19.
18. Evensen J., Malik Z., Moan J. Ultrastructural changes in the nuclei of human carcinoma cells after photodynamic treatment with hematoporphyrin derivative with tetrasodium-meso-tetra(4-sulphonatophenyl) porphine. Lasers Med. Sci. 3:1988;195-206.
19. J. Falk, Porphyrins and metalloporphyrins, in: Biochim. Biophys. Acta - Library, Vol. 2, Elsevier, Amsterdam, 1964.
20. Fukuda H., Casas A., Chueke F., Paredes S., Batlle A. Photodynamic action of endogenously synthesized porphyrins from aminolevulinic acid, using a new model for assaying the effectiveness of tumoral cell killing. Int. J. Biochem. 25:1993;1395-1398.
21. Gibbs P., Gore M., Jordan P. Investigation of the effect of metal ions on the reactivity of thiol groups in human 5-aminolaevulinate dehydratase. Biochem. J. 225:1985;573-850.
22. Goodman J., Hochestein P. Generation of free radicals and lipid peroxidation by redox cycling of adriamycin and daunomycin. Biochem. Biophys. Res. Commun. 77:1984;799-803.
23. Goormaghtigh E., Chatelain P., Caspers J., Ruysschaert J. Evidence of a specific complex between adriamycin and negatively charged phospholipids. Biochim. Biophys. Acta. 597:1980;1-14.
24. Grant W., Speight P., MacRobert A., Hopper C., Bown S. Photodynamic therapy of normal rat arteries after photosensitization using disulphonated aluminium phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer. 70:1994;72-78.
25. Handa K., Sato S. Generation of free radicals and quinone group containing anticancer chemicals in NADPH-microsome systems as evidenced by sulfite oxidation. Gann. 66:1975;43-47.
26. He X., Sikes R., Thomsen S., Chung L., Jacques S. Photodynamic therapy with Photofrin II induces programmed cell death in carcinoma cell lines. Photochem. Photobiol. 59:1994;468-473.
27. Hermes-Lima M., Valle V., Vercesi A., Bechara E. Damage to rat liver mitochondria promoted by δ-aminolevulinic acid-generated reactive oxygen species: connections with acute intermittent porphyria and lead poisoning. Biochim. Biophys. Acta. 1056:1991;57-63.
28. G. Jori, J. Spikes, Photochemistry of porphyrins, in: C. Smith (Ed.), Topics in Photomedicine, Plenum Press, New York, 1984, pp. 183-318.
29. Kennedy J., Pottier R., Pross G. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J. Photochem. Photobiol. B. 6:1990;143-148.
30. Kriegmair M., Baumgartner R., Knuechel R., Stepp H., Hofstädter F., Hofstetter A. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J. Urol. 155:1996;105-110.
31. Llesuy S., Arnaiz S. Hepatotoxicity of mitoxantrone and doxorubicin. Toxicology. 63:1990;187-198.
32. Lowry O., Rosebrough N., Farr A., Randall R. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
33. Ma L., Moan J., Steen H., Iani V. Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. Br. J. Cancer. 71:1995;950-956.
34. Marcillat O., Zhang Y., Davies K. Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin. Biochem. J. 259:1989;181-189.
35. Mauzerall M., Granick S. The occurrence and determination of 5-aminolevulinic acid and porphobilinogen in urine. J. Biol. Chem. 219:1956;435-437.
36. Nahabedian M.Y., Cohen R.A., Contino M.F., Terem T.M., Wright W.H., Berns M.W., Wile A.G. Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. J. Natl. Cancer Inst. 80:1988;739-743.
37. Niehaus W., Samuelson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 6:1968;126-130.
38. Ohmori T., Podack E., Nishio K., Takahashi M., Miyahara Y., Takeda Y., Kubota N., Funayama Y., Ogasawara H., Ohiro T., Ohta S., Salio N. Apoptosis of lung cancer cells caused by some anticancer agents (MMC, CPT-11, ADM) is inhibited by Bcl-2. Biochem. Biophys. Res. Commun. 192:1993;30-36.
39. Petersen C., Lu J., Sun Y., Peterson C.A., Shiah J., Straight R., Kopecek J. Combination chemotherapy and photodynamic therapy with N-(2Hyroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice. Cancer Res. 56:1996;3980-3985.
40. Pollakis G., Goormaghtigh E., Ruysschaert J. Role of quinone structure in the mitochondrial damage induced by antitumor anthracyclines: comparison of adriamycin and 5-iminodaunorubicin. FEBS Lett. 155:1983;267-272.
41. Reich S., Bachur N. Contact dermatitis associated with adriamycin (NCS-123127) and daunorubicin (NSC-82151). Cancer Chemother. Rep. 59:1975;677-678.
42. Reilly J., Neifeld J., Rosenberg S. Clinical course and management of accidental adriamycin extravassation. Cancer. 40:1977;2053-2056.
43. Revis N., Marusic N. Glutathione peroxidase activity and selenium concentration in the hearts of doxorubicin-treated rabbits. J. Mol. Cell Card. 10:1978;945-951.
44. Roberts D., Cairnduff F. Photodynamic therapy of skin cancer: a review. Br. J. Plast. Surg. 48:1995;360-370.
45. Scolnik A., Rubio M., Colombo L., Comolli R., Caro R. Further studies on the histamine metabolism in the M2 adenocarcinoma. Biomed. Pharmacother. 38:1984;465-467.
46. Sinha B. Binding specificity of chemically and enzymatically activated anthracycline anticancer agents to nucleic acids. Chem.-Biol. Interact. 30:1980;67-77.
47. Sinha B., Gregory J. Role of one-electron and two-electron reduction products of adriamycin and daunomycin in deoxyribonucleic acid binding. Biochem. Pharmacol. 30:1981;2626-2630.
48. Snyder H., Verma A., Trifiletti R. The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. FASEB J. 1:1987;282-297.
49. Tritton T., Yee G. The anticancer agent adriamycin can be selectively cytotoxic without entering cells. Science. 217:1982;248-250.
50. A. Vigevani, M. Williamson, Doxorubicin, in: K. Florey (Ed.), Analytical Profiles of Drug Substances, Academic Press, New York, 1980, pp. 246-270.
51. Washbrook R., Fukuda H., Batlle A., Riley P. Stimulation of tetrapyrrole synthesis in mammalian epithelial cells in culture by exposure to aminolevulinic acid. Br. J. Cancer. 75:1997;381-388.